Diffuse midline glioma, once called diffuse intrinsic pontine glioma, is an aggressive brain cancer that's most common in children. Treatment is usually radiation therapy, with the goal of improving comfort and reducing symptoms.
Update Date: 13.06.2025
Diffuse midline glioma (DMG) is a rare type of cancerous brain tumor. It's most common in children between the ages of 5 and 10 years old, though it can also affect adults. The name means:
The term "diffuse intrinsic pontine glioma" (DIPG) used to be used for tumors in the pons area of the brain. Now the term DMG is used to describe these tumors instead of the older term, DIPG. DIPG also may be called H3K27-altered DMG.
The name DIPG means:
DMG is an aggressive type of cancer. Symptoms of DMG usually start suddenly and quickly get worse. DMG may be diagnosed with a review of symptoms, a brain MRI and other tests. There is no cure for DMG. The most common treatments are radiation therapy and chemotherapy. These treatments aim to ease discomfort and help extend life, but they do not cure the cancer.
Symptoms of diffuse midline glioma (DMG) depend on where in the central nervous system the tumor is growing. Symptoms at first may be mild and easy to overlook. But they get worse over a few weeks or months. It's very difficult to diagnose DMG in the early stages.
Common symptoms of DMG include:
Make an appointment with a doctor or other healthcare professional if you have any symptoms that worry you.
The cause of diffuse midline glioma (DMG) isn't completely understood. It's thought to be caused by a gene change that is not expected, such as a random mistake. Genes provide a set of instructions for every cell that tell it how to grow and function. Gene changes, also called mutations, happen when there is an error in these instructions.
The mutations that cause DMG affect the H3K27-altered gene, which is a histone gene. Histone genes help package DNA in cells and manage which genes are turned off or on. When histone genes change, cells cannot regulate themselves properly and don't stop growing when they should. This allows the cells to multiply very quickly and form a tumor.
Another cause of DMG is a change, also called disruption, in the healthy growth of glial cells. Glial cells are part of the white matter of the brain. They support healthy cell development and function. Also caused by the histone gene mutation, this disruption causes the glial cells to grow out of control.
It's possible that DMG may be related to the rapid brain growth of children between the ages of 5 and 10, since this is the most common age for people to be diagnosed with DMG. This time period where the brain grows rapidly may make the brain at risk for these changes in genes.
There are no known risk factors for diffuse midline glioma and no known way to prevent these tumors.
Diffuse midline glioma (DMG) is usually diagnosed through a combination of methods. Your healthcare professional usually starts by reviewing your symptoms, giving you a physical exam and taking your medical history.
The main tool used to diagnose DMG is MRI. This imaging test can find these types of tumors based on their location and features, such as borders that are not well defined. Usually, dye isn't needed as part of the MRI.
If MRI cannot tell the difference between DMG and other gliomas, a biopsy may be done. A biopsy is a procedure that removes a small sample of tumor tissue for study under a microscope in a lab. This exam can diagnose DMG by testing for the H3K27-altered gene mutation in the tumor sample.
Diffuse midline glioma (DMG), is a very aggressive brain tumor that spreads very quickly. There isn't a cure for DMG, but treatments can help manage symptoms so that people with DMG can live longer and more comfortably.
The most common treatment for DMG is radiation therapy. Radiation therapy uses precise, highly concentrated beams of energy to destroy the tumor cells. This treatment usually is given in multiple sessions over about six weeks. It can slow down the growth of the tumor and help reduce some of the symptoms it causes.
Unfortunately, DMG tumors often grow back after radiation therapy.
Usually, surgery isn't an option for these types of tumors because of where they grow in the brain. They grow in the midline, where essential parts of the brain are found. For this reason, surgery can be too risky. Also, the poorly defined edges of the tumor make it difficult to remove with surgery.
Chemotherapy, which is medicine designed to kill cancer cells, usually isn't effective for DMG. But sometimes, chemotherapy may be used along with radiation therapy.
Palliative treatment does not aim to cure cancer but to make life better and manage symptoms such as difficulty swallowing, pain, headaches, and difficulty walking and moving around. Palliative treatment for DMG can include:
Researchers are studying new medicines to treat diffuse midline glioma and new ways of delivering them. Research includes new chemotherapy medicines that target the changed genes in DMG tumors.
Clinical trials are studying medicines that target these cancer cells specifically and deliver them directly to the tumor via a catheter and other novel methods.
Clinical trials also are looking at immunotherapy treatments for DMG. Immunotherapy medicines help the body's immune system find and destroy cancer cells. These medicines include immune checkpoint inhibitors, monoclonal antibodies and vaccines. All of these treatments target cancer cells through the immune system.
Current clinical trials are investigating the use of chimeric antigen receptor (CAR)-T cell therapy. In this treatment, white blood cells called T cells are removed from the blood. In a lab, scientists change these T cells and add a receptor called a CAR. The CAR allows the T cells to track and find cancer cells more easily.
Scientists then grow and multiply the CAR-T cells in a lab, producing millions of very powerful cells. These CAR-T cells are put back into the blood through a needle placed in a vein in the arm, also called an IV. CAR T-cells can keep living and working in the body for a long time, so they're sometimes called a "living drug."
Every person with DMG and every diagnosis is different. DMG is usually fatal. Life expectancy is usually between 9 and 12 months after diagnosis. Most people survive less than a year after diagnosis. Some people live longer with DMG. This depends on several factors, including how well they respond to treatment and the tumor grade at diagnosis. Clinical trials can help people with DMG live longer.
A healthcare team can provide support and guidance for end-of-life care.
Learning that you have a diffuse midline glioma can be overwhelming and frightening. But you can take steps to cope after your diagnosis.
Write down your questions and bring them to your appointments. As your healthcare professional answers your questions, take notes. Or ask a friend or family member to come along to take notes.
The more you and your family know and understand about your care, the more confident you'll feel when it's time to make treatment decisions.
Find someone you can share your feelings and concerns with. You may have a close friend or family member who is a good listener. Or speak with a clergy member or counselor.
You may find it helpful to talk with other people who have diffuse midline glioma. Ask your healthcare team about support groups for people with DMG. These support groups may be available online and in your area.
Check with your healthcare professional to see if it's safe for you to exercise. Get enough sleep so that you feel rested.
Reduce stress in your life by taking time for relaxing activities, such as listening to music or writing in a journal.
If you have symptoms that worry you, make an appointment with a doctor or other healthcare professional. If you have DMG, you'll likely be referred to specialists, such as:
Here's some information to help you get ready for your appointment.
Questions to ask at your first appointment include:
Questions to ask an oncologist or a neurologist include:
In addition to the questions that you've prepared, don't hesitate to ask any other questions that may come up during your appointment.
Be prepared to answer questions about your symptoms and your health history. Questions may include:
© 2025 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use